TABLE 3.
Group | Chemical | Treatment | Body weight (g) | Consumption (/rat/day) | ||
Initial | Final | Food (g) | Water (ml) | |||
1 | DEN | 5% Tween 80 | 92 ± 6.3 | 401 ± 46.1* | 17 ± 4.5* | 24 ± 7.6* |
2 | DEN | CRE 100 mg/kg BW | 92 ± 6.8 | 407 ± 39.4 | 19 ± 3.5 | 25 ± 11.3 |
3 | DEN | CRE 500 mg/kg BW | 93 ± 7.4 | 421 ± 28.6 | 20 ± 4.4 | 28 ± 9.6 |
4 | DEN | RRE 100 mg/kg BW | 92 ± 4.2 | 401 ± 23.4 | 18 ± 4.3 | 23 ± 8.6 |
5 | DEN | RRE 500 mg/kg BW | 92 ± 7.8 | 395 ± 28.0 | 20 ± 3.7 | 24 ± 6.8 |
6 | DEN | VA 75 mg/kg BW | 93 ± 8.7 | 441 ± 24.6 | 22 ± 4.9 | 28 ± 7.6 |
7 | NSS | 5% Tween 80 | 93 ± 13.3 | 467 ± 48.9 | 23 ± 6.0 | 31 ± 4.7 |
8 | NSS | CRE 500 mg/kg BW | 93 ± 4.2 | 457 ± 15.7 | 23 ± 4.8 | 30 ± 5.8 |
9 | NSS | RRE 500 mg/kg BW | 93 ± 4.1 | 453 ± 38.8 | 23 ± 5.3 | 29 ± 4.0 |
Values are expressed as mean ± SD.
*Significantly different from the negative control (group 7), p < 0.05.
CRE, cooked glutinous purple rice extract; RRE, raw glutinous purple rice extract; VA, vanillic acid; DEN, diethylnitrosamine; NSS, normal saline solution.